2019 annual financial data
ImmuCell Corporation 2019 Operating margin
ImmuCell Corporation 2019 operating margin with verified reported values.
Direct answer
Operating margin was -6.95%.
Operating income was -954,000 USD and net income was -1,296,000 USD.
Operating cash flow was 233,511 USD.
Get free ImmuCell Corporation email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 13,723,000 USD
- Operating income
- -954,000 USD
- Net income
- -1,296,000 USD
- Operating cash flow
- 233,511 USD